We are a biotech company located at  Windsor,  Canada,  our business is serving diagnostic industry.

Recombinant protein and lateral flow immunoassay  product development and production are our core technologies, currently we are focusing on the rapid test products in infectious diseases for global market.

Contact service to develop rapid test product for diagnosis   through specific antibody is our another business, we take
the service from protein sequence to final rapid test product.      

 We also serve research area and pharmaceutical industry
for protein expression in E. coli and yeast expression system        as well as transient and stable expression in drosophila  and
mammalian cell line such as CHO from protein  sequence
to purified protein.

                             News    Room
                     ( Updated on July 18, 2014 )

   Lateral flow immunoassay devices:

             Saliva HIV1/2 antibody rapid test available now
              
               Our Dengue NS1 rapid test can detect NS1 antigen with
               a minimal value 3 of  S/CO ( signal / cutoff  ) tested by 
               Panbio ELISA kit;

              Our dengue virus IgG/IgM rapid test starts small quantity 
              production;
              
              Our M. pneumonia IgM rapid test trial in Taiwan now;

     New antibodies for your product: 

               Paired antibodies for ELISA and lateral flow immuoassay;

               Drug abuse reagents for rapid test are available now;              

               Antibody to test M. tuberculosis antigen in urine;

               Antibody to test T. vaginalis P65 for rapid test;

               Paired monoclonal antibody for dengue NS1 rapid test;

    New recombinant antigens:

              Serum HPV typing antigen kit for HPV 6/11/16/18

                Hepatitis A virus VP3 antigen

        Questions, please inquire for info@immunoassay.ca